Vendor Intelligence Report: YB Peptide

Published 13 Jun 2026. 21-page investigative report on who is behind YB Peptide: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

YB Peptide shows an 83% overall Finnrick pass rate across 18 tests, with Retatrutide the stronger signal and Tesamorelin the weak spot. The full report maps the 2025 storefront trail against the…